Solara Active Pharma Sciences Ltd - 541540 - Announcement under Regulation 30 (LODR)-Change in Directorate
We hereby inform you that based on the recommendations of the Nomination & Remuneration Committee, the Board of Directors of the Company has appointed Mr. Rajendra Kumar Srivastava as Additional Non-Executive Independent Director and Mr. Rajiv Vijay Nabar as Additional Non- Executive Non-Independent Director of the Company with effect from November 14, 2023. Solara Active Pharma Sciences Ltd - 541540 - Unaudited Financial Results For The Quarter Ended September 30, 2023
Unaudited Financial Results for the quarter ended September 30, 2023 Solara Active Pharma Sciences Ltd - 541540 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015, kindly note that the Company, as part of investors engagement activities, has scheduled a conference call with the investors and analysts on Tuesday, November 14, 2023, to discuss its Q2 financial results. Solara Active Pharma Sciences Ltd - 541540 - Board Meeting Intimation for Considering Unaudited Financial Results For The Period Ended September 30, 2023.
Solara Active Pharma Sciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2023 ,inter alia, to consider and approve unaudited Financial Results for the period ended September 30, 2023. Solara Active Pharma Sciences Ltd - 541540 - Update On Fire Incident At Puducherry Facility.
Update on Fire Incident at Puducherry Facility. Solara Active Pharma Sciences Ltd - 541540 - Announcement Under Regulation 30 Of SEBI (LODR) - Fire Incident At Puducherry Facility.
We wish to inform that there was a fire incidence at our Puducherry Facility during the night hours of November 4, 2023. Solara Active Pharma Sciences Ltd - 541540 - Announcement Under Regulation 30 (LODR) - Grant Of ESOP
Pursuant to applicable provisions of SEBI (LODR) we wish to inform that the Nomination and Remuneration Committee at their Meeting held today approved the grant of 2,50,000 options to eligible employees. Solara Active Pharma Sciences Ltd - 541540 - Appointment Of Chief Financial Officer
In accordance with SEBI (LODR), Regulations, 2015, it is hereby informed that the Board in its meeting held today has approved the appointment of Mr. P.V Raghavendra Rao as Chief Financial Officer of the Company and designated him as KMP with effect from October 26, 2023. Solara Active Pharma Sciences Ltd - 541540 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
In Compliance with Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, we are forwarding herewith a copy of certificate received from M/s Cameo Corporate Services Limited, the RTA of the Company, for the quarter ended September 30, 2023, for your records. Solara Active Pharma Sciences Ltd - 541540 - Closure of Trading Window
In accordance with Company''s Code of Conduct for Prohibition of Insider trading, the trading window for dealing in the securities of the company shall be closed for designated persons and their relatives with effect from Sunday, October 1, 2023, till 48 hours from the date of declaration of unaudited Fianacial results of the Company for the quarter ended September 30, 2023.